Veeva Systems is overvalued, trading at frothy levels despite only ~10% growth, and facing a potential slowdown in 2025; I recommend a sell rating. The company excels in the life sciences vertical ...

KeyBanc lowered the firm’s price target on Veeva (VEEV) to $250 from $260 and keeps an Overweight rating on the shares. Into Q1 earnings, the ...

Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors ...

Veeva Systems (VEEV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance ...

PLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with ...

CHICAGO – 1 April, 2025 - EVERSANA, a global provider of commercial services to the life sciences industry, today announced it has been named an official Veeva AI Partner, managed by Veeva Systems, a ...

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva ...

Enabling such a possibility is Veeva Commercial Cloud, which includes the Vault Platform, consisting of Content (PromoMats); Medical (MedComms, MedInquiry); CRM Suite (Core CRM, Events ...

Here’s why. The team, the Double-A affiliate of the Baltimore Orioles -- shared two logos. One is a bird perched on a bat; the bird is an American oystercatcher with a long orange-red bill that ...